Monday, January 24, 2011

Breast cancer drug is also useful against lung cancer

Washington - Tamoxifen, an antiestrogen drug used to treat certain types of breast cancer, may also contribute to reducing mortality in people with lung cancer, according to a study released Monday by The Cancer Journal from the United States. Previous studies have shown that women who were hormone therapy with estrogen to treat the effects of menopause had an increased risk of dying from lung cancer.

The study published on Monday is based on the assumption that blocking estrogen may improve survival in people with lung cancer. Researchers examined 6,655 women who had breast cancer between 1980 and 2003, according to the tumor registry of Geneva, of which 3,066, or 46% were treated with antiestrogen.

The study coordinated by Dr. Elisabetta Rapita, which followed the health of women by 2007, shows that patients who received Antiestrogens had 87% lower risk of death from lung cancer that outrasNo However, the study highlights significant effect of treatment with Antiestrogens the risk of developing lung cancer.

"Our findings support the hypothesis that there is a hormonal influence in lung cancer," said Rapita. "If future studies confirm our findings and determine that the antiestrogen agents improve the survival of people with lung cancer, this can have a substantial impact on clinical practice, "he added.

No comments:

Post a Comment